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Introduction
Magnetic ion channel activation (MICA) technology 
enables a level of remote control over the molecular 
functions of nanoparticle-tagged cells using magnets act-
ing over a distance, that is, from outside the body.1,2 The 
MICA principle involves surface functionalising super-
paramagnetic iron oxide nanoparticles (SPIONs) with a 
biomolecule – commonly either an antibody or ligand.3 A 
moving external magnetic field then applies a dynamic 
force (torque) to the nanoparticle which delivers mechan-
ical forces to the target, resulting in mechanotransduction 
or activation of downstream signalling (Figure 1). We 
have previously demonstrated that ion channels,4,5 integ-
rins,4–7 and Wnt receptors8 can be activated using this 
method, allowing researchers external, electronic control 
over complex biological pathways and downstream stem-
cell differentiation.
The TREK1 mechanosensitive ion channel can be 
remotely controlled using magnetic nanoparticles conju-
gated with an anti-TREK1 antibody, and that this acts as a 
powerful stimulus for driving bone repair.2,4 TREK1 is a 
two-pore-domain potassium channel expressed in multiple 
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tissues.6 The mechanically gated TREK1 ion channel can 
be remotely activated by attaching conjugated nanoparti-
cles to the intracellular loop region and applying an oscil-
lating magnetic field, resulting in observable changes in 
whole-cell electrophysiology.5 Directing mechanotrans-
duction via TREK1 has been shown to result in the osteo-
genic differentiation of mesenchymal stem cells (MSCs) 
and increased expression of both osteogenic genes (colla-
gen I, osteopontin and CBFA1) and chondrogenic genes 
(SOX9 and collagen II).5 Developing the sophistication of 
this nanoparticle-based mechanotransduction technique 
using in vitro culture5 through to three-dimensional (3D) 
cell culture, organotypic ex vivo4 and in vivo2,9 models, we 
have demonstrated how mechano-stimulation of human 
mesenchymal stem cells (hMSCs) using magnetic nano-
particles results in differentiation towards the bone and 
cartilage lineage.1,3
Using a chick foetal femur model of endochondral ossi-
fication,10 we have previously reported the effects of 
injecting a population of hMSCs which had been tagged 
with TREK1-targeting nanoparticles into the cartilaginous 
epiphysis of an organotypically cultured foetal femur.4 
After 14 days in culture, a large amount of de novo bone 
formation was observed throughout the epiphysis, particu-
larly in the region immediately below the outer superficial 
layer of the tissue. In the magnet-stimulated femurs 
injected with MSCs tagged with TREK1 nanoparticles, an 
average of 31% more mineralisation was formed com-
pared to controls. This substantial effect was generated 
from just a small number (103) of injected cells, posing 
questions about the underlying biological mechanism that 
was being triggered. We developed two hypotheses: (1) the 
nanoparticle-tagged stem cells were migrating to the sub-
surface of the epiphysis and directly producing bone, or 
(2) the bone formation was created by native chick cells in 
response to unknown factors secreted by the mechanically 
activated human stem cells. Both theories have generated 
some support in the literature, with some evidence of mag-
net-guided migration in nanoparticle-labelled rat bone 
marrow MSCs11 and emerging evidence the mechanotrans-
duction results in the release of paracrine factors from 
MSCs that drive bone formation.12
Deciphering this mechanism in a complex, 3D, organo-
typic foetal tissue proved to be extremely technically 
challenging, so we simplified our methodology to investi-
gate these two hypotheses under more controlled in vitro 
conditions. In this article, we report our results from (1) 
using a transwell migration assay to determine the effects 
of magnetic nanoparticles on hMSC motility and mobili-
sation and (2) a novel two-dimensional (2D) co-culture 
method for determining the paracrine effects of mechani-
cally stimulated hMSCs on surrounding foetal chick epi-
physeal cells (CECs).
The aims of this investigation are to shed further light 
on the mechanisms behind MSC responses to mechanoac-
tivation and the subsequent effects on surrounding tissue 
homeostasis and repair. The overall goals are to examine 
how MICA nanoparticle technology can be used to 
remotely control the tissue regeneration process. Magnetic 
nanoparticles have existing regulatory approval, and their 
long-term safety has been demonstrated.13,14 The efficacy 
and mechanism of action for MICA technology is there-
fore of considerable interest for translational tissue engi-
neering and regenerative medicine.
Methodology
Human MSC culture
Human MSCs were obtained from a bone marrow aspirate 
(Lonza, USA) and cultured to passage three in 
basal Dulbecco’s modified Eagle’s medium (DMEM) 
Figure 1. MICA activation of the TREk1 stretch-activated ion channel. (a) Superparamagnetic ion oxide nanoparticles (SPIONS) 
were surface functionalised with antibodies specific to the mechanosensitive intracellular loop region of the TREK1 ion channel. (b) 
Attachment of the nanoparticle to the ion channel allows the ion channel to be activated (opened) using an external magnetic field. 
(c) Tagging TREK1 in hMSCs allows remote control of mechanotransduction using magnets, such as the (i) MICA bioreactor moving 
magnetic array used in this investigation, and (ii) remote control of injected hMSCs as reported by Henstock et al.4
Henstock et al. 3
containing 10% foetal calf serum (FCS) and 1% penicil-
lin–streptomycin. A single donor was used (24 years old 
healthy male).
Magnetic nanoparticle labelling
Nanomag superparamagnetic nanoparticles of 1 mg (car-
boxyl-coated, 300 nm in diameter; Micromod, Rostock, 
Germany, http://www.micromod.de) were surface activated 
by washing in sterile 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide hydrochloride and N-hydroxysuccinimide in 
0.5 M (2-(N-morpholino)ethanesulfonic acid) MES buffer, 
adjusted to pH 6.3 with Na2CO3 for 1 h at room tempera-
ture, recovered by magnetic separation, and washed in 
0.1 M MES buffer. Nanoparticles (1 mg) were then conju-
gated to either 10 μg of RGD-tripeptide or 10 μg of 
TREK1-Ab (Alomone Labs, Jerusalem, Israel, http://www.
alomone.com) by mixing together in 1 ml of 0.1 M MES 
buffer for 3 h. Attachment of the (arginylglycylaspartic 
acid) RGD-coated nanoparticles to their targets in the 
MSCs was achieved by culturing the hMSCs in suspension 
in serum-free media for 3 h followed by incubation with 
125 μg of particles per 106 cells with intermittent agitation. 
The cells were centrifuged, washed and immediately used 
in experiments. Because the TREK1 antibody epitope is 
intracellular, these particles were first coated in 40 ng of 
N-(1-(2,3-dioleoyloxy)propyl)-N, N, –trimethylammonium 
methyl-sulphate to aid nanoparticle uptake.
Magnetic force bioreactor
Magnetically stimulated groups were placed in an incuba-
tor (37°C, 5% CO2) above a custom-built vertical oscillat-
ing magnetic force bioreactor (MICA Biosystems, 
West Midlands, U.K., http://micabiosystems.com), thus 
maintaining otherwise standard culture conditions. 
Nonstimulated control groups were kept in identical con-
ditions (without magnetic field). Magnetically stimulated 
groups were exposed to a maximum 25-mT magnetic 
field from an array of permanent magnets (NdFeB) situ-
ated beneath the culture plates at a frequency of 1 Hz. 
Magnetic stimulation was performed in daily 1-h sessions 
as described below.
Magnetic field mapping
The magnetic field strengths, polarities and gradients pro-
duced by the permanent magnetic arrays were mapped 
and modelled at a resolution of 0.2 × 0.2 mm using a 
Magscan 300 instrument (Redcliffe Magtronics, Dartford, 
UK). The field maps and polarities at varying distances 
were determined by altering the distance between the 
magnetic array’s and the detector up to a maximum dis-
tance of 84 mm from the array. This allowed estimations 
of the magnetic field gradients that were applied to the 
magnetic nanoparticle to be calculated.
Transwell migration assay
To determine if SPION-labelled hMSCs migrate towards 
the magnetic gradient, hMSCs were labelled with the live 
cell tracker dye PKH26, using the manufacturers standard 
protocol (Phanos Technologies via Sigma Aldrich). 
PKH26-labelled cells (103) were placed in upper chamber 
of a 6.5-mm FluoroBlok transwell (24-well plate) with 
8 µm pores. The plates were then exposed to the magnetic 
force bioreactor for 1 h per day in line with our standard 
MICA protocols. Migration across the FluoroBlok mem-
brane towards the oscillating magnet was quantified by 
directly quantifying fluorescence on the underside of the 
membrane after 96 h. The following negative controls 
were used: hMSCs alone, hMSCs incubated with blank 
(unconjugated) nanoparticles and with 30% FCS in the 
lower chamber acting as a positive control for migration.
Chick foetal femur isolation and cell culture
Intact femurs were removed from freshly killed Dekalb 
white chick foetuses after 11 days of gestation and care-
fully cleaned of all muscle tissue by rolling on sterile tis-
sue. Isolatedemurs measured approximately 7 mm at 
isolation. The epiphyses were removed from the femurs 
and incubated overnight in a 1 mg/ml solution of colla-
genase and centrifuged at 400 g to recover the epiphyseal 
chondrocytes, which were then allowed to attach and pro-
liferate on tissue culture plastic (T-flasks) for 48 h in 
DMEM containing 10% FCS. The cells were cultured at 
37°C and at 5% CO2 in a humidified incubator, with cul-
ture medium being completely replaced every 24 h.
Human MSC chick co-culture assay
To determine generally enhanced migration and obtain 
evidence for any paracrine effects of nanoparticle mech-
ano-activated cells on surrounding CECs, we established a 
localised co-culture assay. In this experiment, a 10 μl 
droplet containing 103 PKH26-labeleld hMSCs was placed 
into the exact centre of a 6-well plate. These were allowed 
to adhere for 3 h, at which point 106 CECs were seeded on 
top of the hMSCs in 2 ml media. A semi-osteogenic media 
was used as in the original organotypic culture experiment 
previously reported:4 DMEM containing 10% FCS, 1% 
penicillin–streptomycin and 150 μg⋅ml−1 ascorbic acid, 
2 mM sodium β-glycerophosphate, and 10−8 M dexameth-
asone (all from Sigma Aldrich, Cambridge, U.K). The co-
cultures were maintained for 28 days with media changes 
every 48 h and daily exposure to the standard MICA proto-
col described above (1 h per day). Controls of the hMSC 
droplet alone and the chick-derived epiphyseal cells alone 
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were used. After 28 days, the spread of hMSCs from the 
initially seeding dot was quantified by area scan on a fluo-
rescence plate reader. Alkaline phosphatase activity in the 
media was also quantified (protocol described below) and 
the plates were sequentially stained for calcium and total 
collagen, both of which were subsequently quantified 
(protocol described below).
Alkaline phosphatase activity
Alkaline phosphatase activity in the culture medium was 
measured by taking a 50-μl sample of the medium and 
quantifying the dephosphorylation of p-nitrophenyl phos-
phate, a phosphatase substrate that turns yellow 
(λmax = 405 nm) when dephosphorylated by alkaline phos-
phatase after 10 min of incubation at room temperature. 
Readings were obtained immediately and then at 5-min 
intervals to establish that data were acquired within the lin-
ear range of the assay. Results are reported following 
10 min of incubation at room temperature.
Calcium quantification
Media was removed from the plates and these were gently 
washed with phosphate-buffered saline (PBS). Calcium 
deposits on the plate were stained with a 1% solution of 
Alizarin red, which was then washed with water until 
residual unbound dye was removed. The plates were then 
imaged using a plate scanner. Quantification of total cal-
cium in each well was by immersing the alizarin-stained 
samples in 5% cetylpyridinium chloride (Sigma Aldrich) 
solution for 2 h, yielding a purple destain solution contain-
ing the solubilised cetylpyridinium–alizarin complex, 
which was quantified in a spectrophotometer at 562 nm.
Collagen quantification
Total collagen was quantified using the collagen stain, 
sirius red (Direct red 80, Sigma Aldrich), an anionic dye 
with sulphonic acid side chain groups which interact with 
the side chain groups of the basic amino acids present in 
collagen. Specific affinity of the dye for collagen under the 
assay conditions is due to the elongated dye molecules 
becoming aligned parallel to the long, rigid structure of 
native collagens that have intact triple helix organisation. 
A small quantity of (1 ml) 1% w/v sirius red S in dH20 was 
added to each well and incubated at room temperature for 
20 min, after which the unbound dye was removed and the 
wells were gently washed with water. The plates were 
imaged using the area scan function of the plate reader at 
absorbance 540 nm to determine where in the plate the col-
lagen was being deposited. The collagen-dye complex was 
the dissociated in 1 ml 0.5 M NaOH, and the absorbance of 
the solution at 540 nm was measured in a spectrophotom-
eter. The assay was calibrated against a standard curve of 
12.5–100 μg/ml rat tail collagen (type-I collagen from rat 
tail, Sigma, UK).
Results
The magnetic field strengths of the arrays were measured 
across a range of distances in order to determine the applied 
magnetic field gradients experienced in vitro during the 
migration and mechanotransduction assays (Figure 2). The 
arrays displayed magnetic field strengths that peaked at 
approximately 300 mT when positioned close to the detec-
tor/well-plate base, and the magnetic field profiles appeared 
to be regular and well defined as shown by cross-sections 
of the magnetic field arrays (Figure 3). The magnetic field 
strength decreased exponentially as a function of distance 
from the detector with minimum field strengths of approxi-
mately 1 mT (at a distance of 84 mm), at this distance the 
magnetic field profile became irregular.
Our initial experiment used FluoroBlok transwell inserts 
to determine the migration of hMSCs tagged with 
TREK1-Ab conjugated nanoparticles towards the magnet 
(Figure 4), with the results reflecting the number of MSC 
which had migrated across the membrane towards the stim-
ulus (either magnet or serum in the positive control). 
TREK1-tagged MSCs were found to migrate more towards 
the magnet (p = 0.02) than the MSC control group (which 
had neither nanoparticles nor magnet). However, all experi-
mental groups (hMSCs tagged with unconjugated nanopar-
ticles, untagged cells exposed to a magnetic field or 
TREK1-labelled cells without a magnet) all showed slightly 
increased migration. Although the TREK1-tagged hMSCs 
Figure 2. Magnetic field gradients. Graphical representation 
of the magnetic field gradients of the six-well permanent array 
used in this investigation. When the array was positioned 
towards the detector/culture, this resulted in a peak magnetic 
field range of 240–400 mT. Away from the sample, at a distance 
of 84 mm, the magnetic field strength was reduced to 1–2 mT. 
The images in red (inset) show representations of the field 
pattern experienced at the well base at each distance from the 
array.
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did migrate more than the control, the 19% increase was 
smaller than the 45% increased chemotactically driven 
migration towards FCS in the positive control group.
Our next experiment sought to determine if the 
TREK1 nanoparticles caused enhanced migration 
perpendicular to the magnetic field. Fluorescently 
labelled (PKH26) hMSCs (103) were placed in a drop in 
the centre of a six-well plate and allowed to adhere, after 
which 106 CECs (derived from foetal femurs isolated at 
e11) were seeded across the entire well (Figure 5). The 
Figure 3. Six-well array magnetic field mapping. 2D model representations of magnetic field strength and polarity of six-well 
permanent magnet arrays. When the magnetic array was closest to the samples (approximately 18 mm), the peak magnetic 
field strength was ±75 mT (a), the peak field strength and field polarity is shown in (c). A representative cross-section of the 
magnetic fields and polarity is shown in (e). When the magnetic array was the furthest (measurable) distance from the samples 
(approximately 84 mm), the magnetic field strength was reduced to ±1.4 mT (b), the field strength and field polarity is shown in (d). 
A representative cross-section of the magnetic fields and polarity is shown in (f).
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Figure 4. Transwell migration of hMSCs tagged with magnetic nanoparticles. PKH26-labelled mesenchymal stem cells (hMSCs) (103 
cells) were placed in the upper chamber of FluoroBlok transwell and migration across the membrane was quantified after 96 h. The 
relative migration of hMSCs labelled with either unconjugated (blank) or TREK1-targeting nanoparticles was compared to unlabelled 
cells (control) and unlabelled cells exposed to the magnet. High concentration foetal calf serum (30% FCS) served as the positive 
control. All groups exposed to the nanoparticles or the magnetic array showed a slight (non-significant) increase in migration over 
the control, and the TREK1-stimulated group (highlighted red) showed significantly increased migration (p = 0.02) over the control. 
Bars represent the experimental mean, and error bars show standard deviation, n = 6. *p < 0.05 and ***p < 0.001.
Figure 5. Migration of hMSCs into a co-culture of chick epiphyseal chondrocytes was not significantly enhanced by 
mechanotransduction. (a) PKH26-labelled hMSCs (103) were placed in the centre of a well in a six-well plate and 106 chick 
epiphyseal cells were seeded on top. The outgrowth of the PKH26-labelled hMSCs (b) from the central seeding dot was quantified 
after 28 days using the area scan function (c) of a fluorescence plate reader. (d) No significant migration was observed in either 
the control or TREK1 nanoparticle-tagged hMSCs. (e) Statistical analysis showed that there was no significant migration across the 
plate, and that the hMSCs remained in the same place for the duration of the experiment (28 days). (f) Error bars show standard 
deviation, n = 6.
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area scan function of a plate reader was used to detect 
the presence of fluorescent cells at measurement posi-
tions radially from the seeding position. After 28 days, 
we observed that there was slight but not significant 
migration of the PKH26-labelled hMSCs from each 
group into the surrounding area, as determined by the 
lack of fluorescence signal away from the original cen-
tral seeding area.
Collagen content of the cultures was determined by 
staining the wells with Sirius red dye (Figure 6). The CECs 
alone were shown to have a uniform distribution of colla-
gen at each measurement point, whereas the addition of 
hMSCs resulted in a proportional increase in collagen dep-
osition closest to the hMSCs (coefficient of linear regres-
sion, R2 = 0.8513). When stimulated with TREK1 
nanoparticles, the collagen deposition across the entire 
plate was shown to be significantly enhanced (by 60%–
90%) at each measurement point, and again was propor-
tional to the proximity to the hMSC colony (coefficient of 
linear regression, R2 = 0.9875).
The co-cultures were subsequently analysed for changes 
in the extracellular matrix composition, starting with calci-
fication/mineralisation across the well (Figure 7). All 
groups were cultured in semi-osteogenic media and in the 
presence of the magnetic array. Control cultures of CECs 
alone had mineralised extracellular matrix, but the amount 
of calcium deposition was increased 37% by the presence 
of hMSCs and further increased to 128% when the hMSCs 
were stimulated via TREK1 nanoparticles. Alizarin red 
staining showed the calcification to be centred on the area 
containing the hMSCs, but with the entire well showing 
evidence of calcification. At the 28 end point, there was no 
significant difference in alkaline phosphatase activity 
across any of the groups.
Discussion
MSCs are being investigated as a powerful cell-based ther-
apy, but their mechanism of action is still largely 
unknown.15,16 Reviews have generally reported that hMSC 
engraftment at implantation sites is variable with their 
long-term survival potentially restricted.17 Nevertheless, 
the ability of MSCs to effect tissue healing and repair in 
many instances is generally recognised, and so the hypoth-
esis which emerges is that the stem cells may have a potent 
secretome that induces effective changes in the surround-
ing cells.18,19 Reports have also suggested that the 
secretome can just as commonly be catabolic rather than 
anabolic,20 so understanding and controlling the mecha-
nisms that regulate the MSC secretome in vivo is begin-
ning to attract attention as a method for controlling healing, 
intervening in disease progression and even diminishing 
the effects of ageing.21
Our previously published data from a chick foetal 
femur microinjected with human MSCs4 demonstrated 
osteogenic differentiation of the injected cells but also 
demonstrated effects remote from the cells in the sur-
rounding tissues. These results lead us to the following two 
hypotheses: (1) hMSCs migrated through the developing 
cartilaginous tissue and themselves generated epiphyseal 
bone or (2) the cells did not significantly migrate, and 
instead, the increased osteogenesis resulted from hMSC–
CEC signalling. To test these competing theories, we first 
measured the ability of the human MSCs to migrate across 
a transwell membrane towards the external magnet used to 
apply a torque to the magnetic nanoparticle on the cell 
membrane. While these cells did migrate more than con-
trol MSCs (without nanoparticles or magnet), their migra-
tion was much lower than chemotaxis towards FCS and 
Figure 6. Collagen deposition by chick epiphyseal cells was enhanced by TREK1 nanoparticle–activated hMSCs. (a) Collagen 
production was increased by ~20% when chick epiphyseal cells were cultured with hMSCs. When hMSCs are mechanically 
stimulated by TREK1 magnetic nanoparticles, collagen production (predominantly from the surrounding chick cells) was increased 
by 60%–90%. (b) A closer examination of collagen deposition as a function of distance from the central hMSC colony shows that 
chick epiphyseal cells closer to the hMSCs produced more collagen (normalised against the chick-only control and presented 
as fold-change). Collagen production by chick cells was inversely proportional to their distance from the hMSCs, indicating a 
biochemical concentration gradient or direct cell–cell contact is required to stimulate upregulation of collagen synthesis. Error bars 
show standard deviation, n = 6; R2 values indicate coefficient of linear regression.
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not significantly different to experimental groups exposed 
to either the magnet or nanoparticles alone. Other groups 
have reported that chemotactic migration of MSCs in vitro 
towards gradients of IGF1 or platelet-derived growth fac-
tor (PDGF) are equal or greater to the positive FCS control 
used in our experiment.22 Our conclusions from this study 
are that at this dose of magnetic labelling, there are not 
sufficient magnetic forces to promote migration towards 
the magnet, thus this slightly enhanced migration in the 
TREK1-tagged hMSC in response to a magnetic field may 
be due to changes in focal adhesions, altered adherence 
and cytoskeletal remodelling caused by the downstream 
effects of mechanotransduction.23
To further investigate migration, we generated a simpli-
fied but robust co-culture assay, in which a droplet of 
TREK1 nanoparticle–tagged and fluorescently labelled 
hMSCs were placed in a small central region of a well 
plate and then surrounded by a confluent layer of chick 
cells. This 2D monolayer setup mimics the 3D organotypic 
model published in our earlier study4 yet allows closer 
interrogation of migration and extracellular matrix (ECM) 
formation without the difficulties of collagen autofluores-
cence which plague 3D cell tracking in organised tissues. 
In our co-culture experiment, hMSCs did not significantly 
migrate out from their central seeding area into the 2D 
regions covered with CECs with or without the TREK 
labelling and magnetic nanoparticles.
We found that the presence in the well of hMSCs 
increased total collagen production by ~20%, and when 
hMSCs are stimulated by TREK1Ab-conjugated magnetic 
nanoparticles, collagen production by surrounding chick 
cells is increased by 60%–90% over controls of just CECs 
alone. Collagen production by chick cells was inversely 
proportional to their distance from the hMSCs, indicating 
that a concentration gradient or direct cell–cell contact is 
required to stimulate upregulation of collagen synthesis. 
This finding is supported by multiple other published stud-
ies in which injected MSCs promoted collagen synthesis 
in vitro24 and in vivo25 especially when employed on cell 
types derived from joint tissues. The effects seen here and 
reported by Henstock et al.4 are generated from a relatively 
small number of hMSCs (103 cells) acting on a much larger 
number of ‘host’ cells (106 CECs in this case). This once 
again reflects the therapeutic potential of injected or 
implanted hMSCs to act as regulators and promoters of 
tissue regeneration in clinical applications such as bone 
non-union or osteoarthritis.26
We also observed that the presence of MSCs caused an 
increased incorporation of calcium into the extracellular 
matrix, and nanoparticle-stimulated MSCs promoted sig-
nificantly increased mineralisation. Chick cells alone were 
capable of mineralising the matrix, while calcification was 
centred in regions containing MSCs and broadly distrib-
uted throughout the rest of the well – there did not appear 
to be the same proximity-based correlation as observed for 
collagen production. This reflects the nature of ECM min-
eralisation which relies on soluble factors in addition to 
ECM proteins such as osteocalcin, and the origin of the 
factors promoting mineralisation is unclear.27
It should be noted that increased collagen synthesis 
from surrounding cells is not necessarily synonymous with 
bone tissue regeneration, and indeed wound healing, scar 
formation and functional regeneration are a complex bal-
ance. When considered alongside the increase in minerali-
sation, the effects we observe appear to be osteoinductive, 
but clearly substantial further work is required to deter-
mine the quality of the ‘bone’ formed under these circum-
stances and the types of collagens produced. A major 
Figure 7. Mineralisation in the co-culture was significantly increased by the presence of hMSCs and activation of hMSC 
mechanotransduction. (a) After 28 days, calcium deposition was determined by staining the plates with alizarin red, which was then 
solubilised with cetylpyridinium chloride and quantified spectrometrically. Calcium deposition was enhanced by the presence of 
the hMSCs (37% increase in total calcium deposition) and further enhanced by the activation of hMSC mechanotransduction (128% 
increase in calcium deposition) compared to the controls lacking MSCs. Visual analysis of the mineral distribution (b) shows that 
the chick epiphyseal cells mineralise the extracellular matrix (i) and mineralisation in the groups containing MSCs was localised in 
the central region surrounding the hMSCs (ii) and TREK-activated MSCs (iii) – the central zone delimiting the MSCs is indicated by 
the blue circles. At the 28 day end point, there was no significant difference in alkaline phosphatase activity in the cell-culture media 
supernatant (c). Error bars show standard deviation, n = 6 and ***p < 0.001.
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outstanding question from this work is the relative contri-
bution of critical matrix proteins such as osteocalcin and 
the larger family of collagen isoforms to the mineralising 
matrix produced by the CECs. Our further investigations 
in the area focus on the ability of cells to generate a func-
tional bone repair through mechanisms which originate 
with mechanoactivation of signalling pathways.2
Our previously published research has demonstrated 
that mechanotransduction pathways can be activated by 
magnetic nanoparticles conjugated with antibodies and 
ligands which bind mechanoreceptors – for example, inte-
grins and ion channels, and we have translated this from in 
vitro research through to a large animal model of bone 
repair.2 Mechanical stimulation is a strong promoter of 
stem-cell differentiation and tissue growth, generating tis-
sues which are mechanically adapted and have functional 
extracellular matrix.28 The MICA technique may therefore 
present a useful, injectable therapeutic in which host cells 
are tagged as a minimally invasive procedure and mechan-
ically activated. The injected cells can then go forward to 
regenerate tissue and furthermore influence surrounding 
tissue regeneration through paracrine signalling to endog-
enous cell communities.29,30
Our conclusions from this study are that the hMSC 
secretome (in an osteogenic media environment) is gen-
erally osteoinductive, resulting in enhancement of bone 
formation from surrounding tissue. Furthermore, 
mechanical stimulation via mechanosensitive stretch-
activated ion channels (in this case TREK1) may 
increase the osteogenic properties of the secretome. In 
this study, we did not conduct any detailed investigation 
into the contents of the secretome, but this will form a 
significant part of our future research. The composition 
of the MSC secretome is currently under investigation 
by a number of research groups, since it has clear appli-
cations as a cell-free driver of biology with uses 
throughout translational and regenerative medicine.31,32 
Our subsequent plans are to quantify the conventional 
signalling molecules (e.g., prostaglandins33 and 
cytokines) and growth factors secreted by the hMSCs 
but recognise that the secretome may equally contain a 
myriad of regulatory molecules including microRNAs.34 
This is clearly both an interesting and challenging body 
of work, but the potential for using magnetic nanoparti-
cles to remotely control anabolic cell signalling could 
be transformative.
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